Our Cartwright Forum on Friday 5th August brought together health practitioners, health consumers and policy makers to:
- Review the impact of screening in the control of cervical cancer in New Zealand;
- Explore emerging issues for New Zealand relating to HPV immunisation in the control of cervical cancer;
- Explore the implications of moving to HPV testing as the primary screening modality to control cervical cancer in New Zealand.
We have been granted permission to share the slides from the speakers’ presentations from the forum. IMPORTANT: please acknowledge the authors if you use any of the content.If you wish to contact the authors’, or access the studies referred to in the presentations, please get in touch with email@example.com and we will help you do this.The National Cervical Screening Programme: Herstory not History from keynote speaker Sandra Coney.The Impact of Screening in the Control of Cervical Cancer
- An overview of Cervical Cancer. From speaker Dr Naomi Brewer, University of Otago;
- Achievements, opportunities and challenges in cervical screening in the wider Auckland region. From speaker Dr Karen Bartholomew, Waitemata DHB;
- (Michelle Delacey, Te Whanau o Waipareira and member of the Metropolitan Auckland Cervical Screening Advisory Group’s Operations Group also spoke without slides).
HPV Immunisation in the Control of Cervical Cancer in New Zealand: Emerging Issues for New Zealand
- HPV Immunisation in the control of cervical cancer. From speaker Rayoni Keith, Ministry of Health;
- HPV and Males. From speaker Adrian Ludlam, University of Auckland and NZ AIDS Foundation;
- Safety of HPV vaccine. From speaker Dr Helen Petousis-Harris, University of Auckland Department of General Practice and Primary Health Care;
- (Phillida Bunkle, Cartwright Collective, also spoke without slides, offering a critical consumer perspective).
The Implications of Moving to HPV Testing as the Primary Screening Modality to Control Cervical Cancer in New Zealand
- The new pathway to primary HPV testing. Presented by Jo Manning on behalf of the National Screening Unit;
- HPV-Negative Results in Women Developing Cervical Cancer: Implications for Cervical Screening Options. From speaker Professor R Marshall Austin, Magee-Womens Hospital of University of Pittsburgh Medical Center;
- The HPV screening policy. From speaker Dr Brian Cox, University of Otago;
- Slides from panel member Dr Peter Fitzgerald, Southern Community Laboratories;
- (Dr Sandy Hall, Women’s Health Action, also spoke without slides).